Search results
Results from the WOW.Com Content Network
1941–1951: Journal of Clinical Endocrinology; 1952-present: Journal of Clinical Endocrinology and Metabolism ... J. Clin. Endocrinol. Metab. Indexing ...
The results showed that people taking semaglutide experienced weight loss over 65 weeks, and this weight loss was sustained over four years on the medication. Plus, there was a 20 percent ...
The journal was established in 2005 as Nature Clinical Practice Endocrinology & Metabolism and obtained its current title in April 2009. [1] The editor-in-chief is Claire Greenhill. [2] According to the Journal Citation Reports, the journal has a 2021 impact factor of 47.564, ranking it 1st out of 146 journals in the category "Endocrinology ...
Metabolism: Clinical and Experimental is a monthly peer-reviewed medical journal covering all aspects of human metabolism. It was established in 1952 and is published by Elsevier . [ 1 ] The editor-in-chief is Christos Socrates Mantzoros ( Harvard Medical School ) who has reinvigorated the journal during his tenure.
Clinical trial number NCT04657003 for "A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight (SURMOUNT-2)" at ClinicalTrials.gov; Clinical trial number NCT04657016 for "A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program (SURMOUNT-3)" at ClinicalTrials.gov
American Society for Clinical Investigation, 2003. Gerald D. Aurbach Laureate Award for Outstanding Translational Research from the Endocrine Society , 2016. Steven Grinspoon is an American physician and a Professor of Medicine at Harvard Medical School, Chief of the Massachusetts General Hospital (MGH), and Metabolism Unit and Director of the ...
The length of the resistin pre-peptide in human is 108 amino acid residues and in the mouse and rat it is 114 aa; the molecular weight is ~12.5 kDa. Resistin is an adipose-derived hormone (similar to a cytokine) whose physiologic role has been the subject of much controversy regarding its involvement with obesity and type II diabetes mellitus .
Studies published in the Indian Journal of Endocrinology and Metabolism focused on the prevalence of metabolic syndrome and its components in different African populations using various criteria. Reports from Lagos, Nigeria , for instance, showed the prevalence rate of metabolic syndrome as high as over 80% among diabetic patients. [ 13 ]